Amlodipine

  • CAT Number: I005298
  • CAS Number: 88150-42-9
  • Molecular Formula: C20H25ClN2O5
  • Molecular Weight: 408.9
  • Purity: ≥95%
Inquiry Now

Amlodipine (Cat No.: I005298) is a long-acting calcium channel blocker medication used in the treatment of various cardiovascular conditions. It is effective in managing angina pectoris, hypertension (high blood pressure), and congestive heart failure. Amlodipine works by relaxing blood vessels, which leads to improved blood flow and reduced workload on the heart, ultimately helping to control blood pressure and relieve symptoms of angina. If you need to, please contact us in time, and we will reply to you as soon as possible within 24 hours.

Catalog Number I005298
CAS Number 88150-42-9
Molecular Formula

C20H25ClN2O5

Purity 95%
Target Calcium Channel
Solubility DMSO: ≥ 30 mg/mL
Storage -20°C
IUPAC Name 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
InChI InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3
InChIKey HTIQEAQVCYTUBX-UHFFFAOYSA-N
SMILES CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
Reference

<p style=/line-height:25px/>
<br>[1]. http://en.wikipedia.org/wiki/Amlodipine
</p>

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!